Vaccinex, Inc. SEC filings VCNX
Vaccinex, Inc. has 475 filings in SEC EDGAR's recent list, going back to Nov 12, 2002. Its latest annual report, Form 10-K, was filed on Apr 15, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2024, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Mar 19, 2025 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| POS AM | Filing | Mar 25, 2025 | — |
| S-8 POS | Filing | Mar 25, 2025 | — |
| S-8 POS | Filing | Mar 25, 2025 | — |
| 424B3 | Prospectus | Oct 25, 2024 | — |
| S-3 | Shelf registration | Oct 16, 2024 | — |
| 424B3 | Prospectus | Jul 8, 2024 | — |
| S-3 | Shelf registration | Jun 27, 2024 | — |
| S-8 | Employee stock plan registration | May 10, 2024 | — |
| 424B3 | Prospectus | May 9, 2024 | — |
| S-3/A | Filing | May 8, 2024 | — |
| S-3 | Shelf registration | Apr 26, 2024 | — |
| 424B3 | Prospectus | Apr 16, 2024 | — |
| S-3 | Shelf registration | Apr 2, 2024 | — |
| 424B5 | Prospectus supplement | Mar 28, 2024 | — |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| S-3 | Shelf registration | Jan 10, 2024 | — |
| 424B4 | Prospectus | Oct 2, 2023 | — |
| S-1MEF | Filing | Sep 28, 2023 | — |
| S-1/A | Amended registration statement | Sep 26, 2023 | — |
| S-1 | Registration statement | Sep 14, 2023 | — |
| 424B3 | Prospectus | Jul 11, 2023 | — |
| S-3 | Shelf registration | Jun 14, 2023 | — |
| 424B5 | Prospectus supplement | May 19, 2023 | — |
| S-3 | Shelf registration | Apr 3, 2023 | — |
| 424B3 | Prospectus | Feb 1, 2023 | — |
| S-3 | Shelf registration | Jan 24, 2023 | — |
| 424B5 | Prospectus supplement | May 17, 2022 | — |
| 424B3 | Prospectus | Apr 29, 2022 | — |
| S-3 | Shelf registration | Apr 11, 2022 | — |
| 424B5 | Prospectus supplement | Sep 9, 2020 | — |
| S-3/A | Form s-3/a | Aug 21, 2020 | — |
| 424B5 | Prospectus supplement | Aug 14, 2020 | — |
| S-3 | Shelf registration | Aug 14, 2020 | — |
| S-3 | Shelf registration | Aug 14, 2020 | — |
| 424B5 | Prospectus supplement | Mar 27, 2020 | — |
| 424B5 | Prospectus supplement | Mar 27, 2020 | — |
| S-3 | Shelf registration | Feb 13, 2020 | — |
| S-3 | Shelf registration | Feb 13, 2020 | — |
| S-3/A | Filing | Sep 27, 2019 | — |
| S-3 | Shelf registration | Sep 3, 2019 | — |
| S-8 | Employee stock plan registration | Aug 21, 2018 | — |
| 424B4 | Prospectus | Aug 10, 2018 | — |
| S-1/A | Amended registration statement | Aug 8, 2018 | — |
| S-1/A | Amended registration statement | Jul 23, 2018 | — |
| S-1 | Registration statement | Jul 9, 2018 | — |
Showing 59 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VCNX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rochester, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1205922
- Former names
- VACCINEX INC (until May 9, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.